Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "mRNA-4157 (V940) Individualized Neoantigen Therapy + Pembro vs. Pembro in High-Risk Resected Melanoma"

193 views
November 1, 2023
Comments 0
Login to view comments. Click here to Login